+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID03193515

Non-Invasive Multiplex ELISA Test to Monitor Patients with a History of Bladder Cancer

Led by Cedars-Sinai Medical Center · Updated on 2026-02-04

300

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new urine test called a multiplex ELISA assay to improve the detection of recurrent bladder cancer in patients with a history of this disease. Current urine tests like voided urinary cytology miss about half of early-stage or low-grade bladder cancers, which are most treatable. This study aims to validate the new test by comparing its results to cystoscopy, an invasive procedure used to monitor bladder cancer recurrence. This observational study involves collecting voided urine samples from patients with a history of non-muscle invasive or muscle invasive bladder cancer treated with bladder-sparing methods or not yet treated, diagnosed within the past 24 months. Participants may be undergoing regular surveillance every 3 to 12 months depending on their risk level. The multiplex ELISA assay results will be compared to those from cystoscopy and other urine tests like voided urinary cytology and NMP22 BladderCheck over a period of two years. Participants will provide informed consent and follow their scheduled surveillance visits for up to two years. Researchers will monitor the sensitivity and specificity of the multiplex ELISA assay by comparing it to cystoscopy results, which involve inserting a camera to inspect the bladder. The study will also compare how well the new test performs against existing urine tests. This non-invasive approach could reduce the need for frequent cystoscopies if shown to be reliable.

CONDITIONS

Brief Title

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Research Team

C

Charles Rosser, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here